Genetic testing for hypertrophic cardiomyopathy: ongoing voyage from exploration to clinical exploitation
More than two decades have elapsed since the SET discovery that sarcomere gene defects cause familial hypertrophic cardiomyopathy (HCM).Since then, genetic testing in HCM has developed and expanded, and is now widely available as a potential clinical service in the Western countries.In the meantime, however, the cross-talk between geneticists and c